Isotracin (Isotretinoin)

Isotretinoin binds to nuclear retinoic acid receptors in skin cells, altering gene expression. This reduces the size and activity of sebaceous glands, lowers sebum production, normalizes follicular keratinization, and exerts anti‑inflammatory effects, addressing the key pathogenic mechanisms of severe acne.

The dosage of Isotracin is individualized by the prescribing clinician based on the patient’s weight, severity of acne, and laboratory parameters. The prescriber determines the appropriate dose and treatment duration, and patients should follow the specific instructions provided by their healthcare professional.

Isotracin is classified as pregnancy category X because isotretinoin is highly teratogenic and can cause severe birth defects. It is contraindicated during pregnancy and should not be used by women who are breastfeeding, as it may pass into breast milk and affect the infant.

To order Isotracin, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Compared with oral antibiotics, isotretinoin offers a disease‑modifying effect rather than merely controlling bacterial growth. Unlike topical retinoids, it works systemically and can treat severe, resistant forms of acne. However, its safety profile requires careful monitoring, especially for teratogenicity and psychiatric effects.

Isotracin should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct light, and ensure the container is tightly closed to maintain stability throughout its shelf life.

Isotracin is taken orally, usually with a meal or a glass of milk to reduce gastrointestinal irritation. The tablet or capsule should be swallowed whole with water and not crushed or chewed, unless otherwise directed by a healthcare professional.

The most serious risks include severe depression, suicidal thoughts, and other psychiatric changes; teratogenic effects causing birth defects; and rare but serious conditions such as inflammatory bowel disease, pancreatitis, and significant liver enzyme elevations. Patients should report any concerning symptoms promptly.

Isotracin should not be used by pregnant women, women planning pregnancy, or nursing mothers. It is also contraindicated in patients with known hypersensitivity to isotretinoin or other retinoids, those with severe liver disease, uncontrolled hyperlipidaemia, or a history of severe psychiatric disorders.